Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions
Roger S. McIntyre, Mohammad Alsuwaidan, Bernhard T. Baune, et al.
World Psychiatry (2023) Vol. 22, Iss. 3, pp. 394-412
Open Access | Times Cited: 237

Showing 1-25 of 237 citing articles:

Psychotropic Drug–Related Weight Gain and Its Treatment
Roger S. McIntyre, Angela T.H. Kwan, Joshua D. Rosenblat, et al.
American Journal of Psychiatry (2024) Vol. 181, Iss. 1, pp. 26-38
Closed Access | Times Cited: 35
Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin
Joshua D. Rosenblat, Shakila Meshkat, Zoe Doyle, et al.
Med (2024) Vol. 5, Iss. 3, pp. 190-200.e5
Closed Access | Times Cited: 25
Association of antidepressants with cataracts and glaucoma: a disproportionality analysis using the reports to the United States Food and Drug Administration Adverse Event Reporting System (FAERS) pharmacovigilance database
Gia Han Le, Sabrina Wong, Angela T.H. Kwan, et al.
CNS Spectrums (2025), pp. 1-15
Closed Access | Times Cited: 1
Comparison of the Efficacy and Safety of Bupropion Versus Aripiprazole Augmentation in Adults with Treatment-Resistant Depression: A Nationwide Cohort Study in South Korea
Dong Yun Lee, Rae Woong Park, Soo Min Jeon
European Psychiatry (2025) Vol. 68, Iss. 1
Open Access | Times Cited: 1
Treatment-resistant depression: role of genetic factors in the perspective of clinical stratification and treatment personalisation
Chiara Fabbri
Molecular Psychiatry (2025)
Closed Access | Times Cited: 1
The Anti-inflammatory Potential of Tricyclic Antidepressants (TCAs): A Novel Therapeutic Approach to Atherosclerosis Pathophysiology
Majid Eslami, Marzieh Monemi, Masoud Nazari, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 197-197
Open Access | Times Cited: 1
Personalized Eicosapentaenoic Acid Therapy for Clinical Depression
Halliru Zailani, David Mischoulon, Simon C. Dyall, et al.
Psychiatric Annals (2025) Vol. 55, Iss. 2
Closed Access | Times Cited: 1
The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data
Giacomo d’Andrea, Mauro Pettorruso, Giorgio Di Lorenzo, et al.
Journal of Affective Disorders (2023) Vol. 348, pp. 314-322
Closed Access | Times Cited: 23
The definition of treatment resistance in anxiety disorders: a Delphi method‐based consensus guideline
Katharina Domschke, Patrik D. Seuling, Miriam A. Schiele, et al.
World Psychiatry (2024) Vol. 23, Iss. 1, pp. 113-123
Open Access | Times Cited: 11
A comparison between psilocybin and esketamine in treatment-resistant depression using number needed to treat (NNT): A systematic review
Sabrina Wong, Angela T.H. Kwan, Kayla M. Teopiz, et al.
Journal of Affective Disorders (2024) Vol. 350, pp. 698-705
Closed Access | Times Cited: 9
Projecting the 10-year costs of care and mortality burden of depression until 2032: a Markov modelling study developed from real-world data
Vivien Kin Yi Chan, Man Yee Mallory Leung, Sandra S. M. Chan, et al.
The Lancet Regional Health - Western Pacific (2024) Vol. 45, pp. 101026-101026
Open Access | Times Cited: 8
Number needed to treat (NNT) for ketamine and esketamine in adults with treatment-resistant depression: A systematic review and meta-analysis
Cameron N. Calder, Angela T.H. Kwan, Kayla M. Teopiz, et al.
Journal of Affective Disorders (2024) Vol. 356, pp. 753-762
Closed Access | Times Cited: 8
Algorithm‐based modular psychotherapy vs. cognitive‐behavioral therapy for patients with depression, psychiatric comorbidities and early trauma: a proof‐of‐concept randomized controlled trial
Elisabeth Schramm, Moritz Elsaeßer, Carolin Jenkner, et al.
World Psychiatry (2024) Vol. 23, Iss. 2, pp. 257-266
Open Access | Times Cited: 8
Recent Advances in the Treatment of Treatment-Resistant Depression: A Narrative Review of Literature Published from 2018 to 2023
J Havlík, Syed Shabab Wahid, Kayla M. Teopiz, et al.
Current Psychiatry Reports (2024) Vol. 26, Iss. 4, pp. 176-213
Closed Access | Times Cited: 6
Clinical Use of Staging in Psychiatry
Giovanni A. Fava
Psychotherapy and Psychosomatics (2024) Vol. 93, Iss. 3, pp. 143-150
Closed Access | Times Cited: 6
Complement C1q/C3-CR3 signaling pathway mediates abnormal microglial phagocytosis of synapses in a mouse model of depression
Qiu-Qin Han, Shi-Yu Shen, Ling‐Feng Liang, et al.
Brain Behavior and Immunity (2024) Vol. 119, pp. 454-464
Closed Access | Times Cited: 6
Protocols and practices in psilocybin assisted psychotherapy for depression: A systematic review
Noah Chisamore, Danica E. Johnson, Margery J.Q. Chen, et al.
Journal of Psychiatric Research (2024) Vol. 176, pp. 77-84
Closed Access | Times Cited: 6
Use of ketamine for treatment resistant depression: updated review of literature and practical applications to a community ketamine program in Edmonton, Alberta, Canada
Carson Chrenek, Bryan Duong, Atul Khullar, et al.
Frontiers in Psychiatry (2024) Vol. 14
Open Access | Times Cited: 5
Amygdala real-time fMRI neurofeedback upregulation in treatment resistant depression: Proof of concept and dose determination
Laurie Compère, Greg J. Siegle, S. Lazzaro, et al.
Behaviour Research and Therapy (2024) Vol. 176, pp. 104523-104523
Open Access | Times Cited: 5
Facts and myths about use of esketamine for treatment-resistant depression: a narrative clinical review
Matteo Di Vincenzo, Vassilis Martiadis, Bianca Della Rocca, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 5
The Co-occurrence of Depression and Obesity
Roger S. McIntyre
The Journal of Clinical Psychiatry (2024) Vol. 85, Iss. 2
Open Access | Times Cited: 5
Treatment expectations and clinical outcomes following repetitive transcranial magnetic stimulation for treatment-resistant depression
Adriano Mollica, Enoch Ng, Matthew J. Burke, et al.
Brain stimulation (2024) Vol. 17, Iss. 4, pp. 752-759
Open Access | Times Cited: 5
Safety and tolerability of esketamine nasal spray versus quetiapine extended release in patients with treatment resistant depression
Roger S. McIntyre, István Bitter, Jozefien Buyze, et al.
European Neuropsychopharmacology (2024) Vol. 85, pp. 58-65
Open Access | Times Cited: 5
Insulin resistance, clinical presentation and resistance to selective serotonin and noradrenaline reuptake inhibitors in major depressive disorder
Anna Julia Krupa, Adrian Andrzej Chrobak, Zbigniew Sołtys, et al.
Pharmacological Reports (2024) Vol. 76, Iss. 5, pp. 1100-1113
Open Access | Times Cited: 5
Psychedelics for the Treatment of Psychiatric Disorders: Interpreting and Translating Available Evidence and Guidance for Future Research
Roger S. McIntyre, Angela T.H. Kwan, Rodrigo B. Mansur, et al.
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 21-32
Closed Access
Page 1 - Next Page

Scroll to top